• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Screening of biological response modifiers (BRMs) for preventive effects on type 1 diabetes mellitus in animal models.

Research Project

Project/Area Number 62870046
Research Category

Grant-in-Aid for Developmental Scientific Research

Allocation TypeSingle-year Grants
Research Field 内分泌・代謝学
Research InstitutionTOHOKU UNIVERSITY

Principal Investigator

SATOH Jo  TOHOKU UNIVERSITY HOSPITAL INSTRUCTOR, 医学部附属病院, 助手 (60125565)

Co-Investigator(Kenkyū-buntansha) SHINTANI Shigeki  TOHOKU UNIV SCHOOL of medicine master, 医学部附属病院, 医員
ABE Toru  TOHOKU UNIV SCHOOL of medicine LECTURER, 歯学部, 講師 (30005079)
NOBUNAGA Toshima  TOHOKU UNIV SCHOOL of medicine Associated PROFESSOR, 医学部, 助教授 (90004754)
TOYOTA Takayoshi  TOHOKU UNIV SCHOOL of medicine PROFESSOR, 医学部, 教授 (40003628)
Project Period (FY) 1987 – 1989
Project Status Completed (Fiscal Year 1989)
Budget Amount *help
¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 1989: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1988: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1987: ¥1,800,000 (Direct Cost: ¥1,800,000)
KeywordsType 1 diabetes / IDDM / NOD mice / BB rats / Immunotherapy / biological response modifier / cytokine / Tumor necrosis factor / インストリン依存型糖尿病 / OK-432 / BRM / TNFα / TNFβ / IDDM / TNF
Research Abstract

We previously reported that a streptococcal preparation (OK-432), a non-immunosuppressive biological response modifier (BRM), inhibited insulitis and development of insulin-dependent diabetes mellitus (IDDM) in NOD mice and BB rats as animal models of IDDM. In this study we screened other BRMS, which were clinically used or possibly to be used, for the possible preventive effects on IDDM of the animal models.
Fifteen kinds of BRMs were screened. Three from the bacteria origin; OK-432, N-CWS and LPS: four from the plant origin; Lentinan, PSK, Glycyrrhizin and Ubenimex; one synthetic product; Lobebzarit disodium (CCA); seven recombinant cytokines; human IL-1alpha , human IL-2, human TNFalpha, mouse TNFalpha , human TNFbeta , mouse IFNgamma, mouse GM-CSF.
Of non-eytokine BRMS, OK-432, LPS and Lentinan strongly inhibited development of IDDM in NOD mice. N-CWS had the weak inhibitory effects. PSK, Glycyrrhizin, Ubenimex and CCA had no suppressive effects on the NOD mice diabetes, although the optimal dose was not examined enough. Only human and mouse TNFalpha out of the various cytokines significantly suppressed IDDM in NOD mice. However, the dose-effect of the other cytokines was not thoroughly evaluated. The effect of TNFbeta is in progress. OK-432 and TNFalpha had the inhibitory effect on diabetes in both NOD mice and BB rats.
These results indicate that the various BRMs have possible therapeutic effects on human IDDM and that the environmental factors of bacteria and plant origins may have the inhibitory effects on the genetically-determined IDDM.

Report

(3 results)
  • 1989 Annual Research Report   Final Research Report Summary
  • 1988 Annual Research Report
  • Research Products

    (39 results)

All Other

All Publications (39 results)

  • [Publications] Takayoshi Toyota: "A dilemma of immunotherapy for type 1 diabetes in human:A pilot study of the immunotherapy with OK-432(a streptococcal preparation)" Best approach to the ideal theraqy of diabetes mellitus. 163-166 (1987)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh: "Treatment with streptococcal preparation(OK-432)Suppresses antiislet autoimmunity and prevents diabetes in BB rats" Diabetes. 37. 1188-1194 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh: "NOD mice with high indence of type 1 diabetes are not T lymphocytopenic" Tohoku J.exp.Med.155. 151-158 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh: "Reconbinant human tumor necrosis factor α suppresses autoimmune diabetes in nonobese diabetic mice" J.Clin Invest.84. 1345-1348 (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shigeki Shintani: "Mechanism of action of streptococcal preparation(OK-432)in prevention of autoimmune diabetes in NOD mice,Suppression of generation of effector cells for pancreatic B cell destruction." J.Immunol.144. 136-141 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh: "Various biological response modifiers inhibit the development of insulin-dependent(Type 1)diabetes mellitus(IDDM)in NOD mice" Current status of prevention and treatment of diabetes complications (Elsevier science publishers BV). 1. 658-661 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh: "Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor α" J.Immunol.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shun-ichi Tanaka: "Increased lipolysaccharide-induced in vivo production of tumor necrosis factor in diabetic status of the diabetic animal models;BB rats,NOD mice and GK rats"

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shigeki Shintani: "Inhibition of cyclophosphamide-induced diabetes in NOD mice by L3T4^+ T lymphocytes"

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Hiroaki Seino: "Suppression of autoimmune diabetes in NOD mice with low dosis of endogenous tumor nerosis factor"

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] 佐藤譲: "TNFとTNF誘起剤によるNODマウスのI型糖尿病発症の抑制" 医学のあゆみ. 147. 63-64 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] 佐藤譲: "糖尿病高率発症系NOD/SendaiマウスはTリンパ球減少性ではない" 糖尿病動物. 2. 25-29 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] 新谷茂樹: "OK-432によるNODマウス糖尿病発症抑制:作用機序の解明" 糖尿病動物. 2. 66-69 (1988)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] 新谷茂樹: "NODマウスCyclophosphamide誘発糖尿病のTリンパ球による発症抑制" 糖尿病動物. 3. 35-39 (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] 清野弘明: "各種免疫修飾剤(BRM)によるNODマウス糖尿病発症抑制と内因性tumor necrosis factor(TNF)誘起能" 糖尿病動物. 3. 46-51 (1989)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Takayoshi Toyota, et al.: "A dilemma of immunotherapy for type 1 diabetes in human: A pilot study of the immunotherapy with OK-432 (a streptococcal preparation)." Best approach to the ideal therapy of diabetes mellitus, 163-166, 1987.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh, et al.: "Treatment with streptococcal preparation (OK-432) suppresses anti-islet autoimmunity and prevents diabetes in BB rats." Diabetes, 37: 1188-1194, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh, et al.: "NOD mice with high incidence of type 1 diabetes are not T lymphocytopenic." Tohoku J. exp. Med. 155: 151-158, 1988.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh, et al.: "Recombinat tumor necrosis alpha suppresses autoimmune diabetes in nonobese diabetic mice." J. Clin. Invest. 84: 1345-1348, 1989.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shigeki Shintani, et al.: "Mechanism of action of a streptococcal preparation (OK-432) in prevention of autoimmune diabetes in NOD mice. Suppression of generation of effector cells for pancreatic B cell destruction." J. Immunol. 144: 136-141, 1990.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh, et al.: "Various biological response modifiers inhibit the development of insulindependent (Type 1) diabetes mellitus (IDDM) in NOD mice." Current status of prevention and treatment of diabetes complications (Elsevier Science Publishers BV) 658-661, 1990.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo Satoh, et al.: "Inhibition of type 1 diabetes in BB rats with recombinant human tumor necrosis factor alpha."

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shun-ichi Tanaka, et al.: "Increased lipopoly-saccharide-induced in vivo production of tumor necrosis factor in diabetic status of the diabetic animal models; BB rats, NOD mice and GK rats."

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Shigeki Shintani, et al.: "Inhibition of cyclophosphamide-induced diabetes in NOD mice by L3T4^+ T lymphocytes."

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Hiroaki Seino, et al.: "Suppression of autoimmune diabetes in NOD mice with low dosis of endogenous tumor necrosis factor."

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1989 Final Research Report Summary
  • [Publications] Jo SATOH: "Recombinant human tumor necrosis factorα suppresses autoimmune diabetes in nonobese diabetic mice" Journal of Clinical Investigation. 84. 1345-1348 (1989)

    • Related Report
      1989 Annual Research Report
  • [Publications] 新谷茂樹: "NODマウスCyclophosphamide誘発糖尿病のTリンパ球による発症抑制" 糖尿病動物. 3. 35-39 (1989)

    • Related Report
      1989 Annual Research Report
  • [Publications] 清野弘明: "各種免疫修飾剤(BRM)によるNODマウス糖尿病発症抑制と内因性tumor necrosis factor(TNF)誘起能" 糖尿病動物. 3. 46-51 (1989)

    • Related Report
      1989 Annual Research Report
  • [Publications] Shigeki Shintani: "Mechanism of action of a streptococcal preparation(ok-432)in prevention of autoimmone diabetes in NOD mice.Suppression of generation of effector cells for pancreatic B cell destruction." Journal of Immanology. 144. 136-141 (1990)

    • Related Report
      1989 Annual Research Report
  • [Publications] Jo SATOH: "Various biological response modifiers inhibit the development of insulin-dependent(Type1)diabetes mellitus(IDDM)in NOD mice." Current status of prevention and treatment of diabetes complications.(Elsevier Science Publishers BV). 1. 658-661 (1990)

    • Related Report
      1989 Annual Research Report
  • [Publications] Jo SATOH: "Inhibition of type1 diabetes in BB rats with recombinant human tumor necrosis factor α" Journal of Immanology.

    • Related Report
      1989 Annual Research Report
  • [Publications] Shun・ichi Tanaka: "Increased lipoplysac charide-induced in vivo proauction of tamor necrosis factor in diabetic status of the diabetic animol models:BB rats NOD mice and GK rats." Diabetes.

    • Related Report
      1989 Annual Research Report
  • [Publications] Jo SATOH: Tohoku J.exp.Med.155. 151-158 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] Jo SATOH: Diabetes. 37. 1188-1194 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] 佐藤譲: 医学のあゆみ. 147. 63-64 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] 佐藤譲: 糖尿病動物. 2. 25-29 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] 新谷茂樹: 糖尿病動物. 2. 66-69 (1988)

    • Related Report
      1988 Annual Research Report
  • [Publications] Shigeki Shintani: J.Immunol.

    • Related Report
      1988 Annual Research Report
  • [Publications] Jo SATOH: Recombinant human tumor necrosis factor suppresses autoimmune diabetes in NOD mice, Recombinant human tumor necrosis factor suppresses autoimmune diabetes in NOD mice,

    • Related Report
      1988 Annual Research Report

URL: 

Published: 1987-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi